Friday, March 28, 2025

Gleneagles Connect #61

View this email in your browser
Gleneagles pioneers transformative Histotripsy treatment for liver cancer in private sector in Asia

Gleneagles is excited to be the first private hospital in Asia to offer Histotripsy treatment, the transformative and non-invasive technology that uses high-intensity ultrasound waves to destroy tumours for liver cancer patients. The service will commence towards the end of March.

Histotripsy was first introduced in Hong Kong last August through a donation by the Li Ka Shing Foundation to the LKS Faculty of Medicine of The University of Hong Kong and initially available in the public healthcare sector on a clinical trial basis. The successful applications and sound clinical outcomes of the technology have paved the way for its expansion into the private sector. Gleneagles is greatly appreciative of having the first HistoSonics system placed at the hospital in order to make this groundbreaking and effective treatment available to more patients.

Histotripsy treatment allows doctors to treat tumours without any incision, radiation or needle, offering a promising alternative to traditional treatments particularly for patients who are not candidates for surgery. Compared to traditional treatments, Histotripsy treatment typically involves minimal pain and fewer side effects and complications. Its non-invasive feature allows shorter hospital stay and much quicker patient recovery.

As a university teaching hospital, we also look forward to contributing to the research on the wider application of this technology to other types of cancers, bringing more options and new hope to more local and regional patients.


Learn more about Histotripsy treatment.

 
港怡醫院為亞洲首家私營醫院 引入變革性Histotripsy系統作肝癌治療

組織碎化技術於去年8月引入香港,由李嘉誠基金會捐贈有關系統予香港大學李嘉誠醫學院,並在公營醫療系統進行臨床試驗。這項技術的成功應用以及理想的臨床效果促使有關治療可擴展到私營醫療機構。感謝李嘉誠基金會將首台HistoSonics系統置於港怡醫院,讓我們可提供這開創性且有效的治療方法,讓更多病人受惠。

港怡醫院為亞洲首家私營醫院引入Histotripsy系統,這項變革性、無創的Histotripsy組織碎化技術利用高強度超聲波破壞癌細胞,醫院將於 3 月底起為肝癌病人提供此項治療服務。

組織碎化技術無需任何切口、輻射或刺針便能治療腫瘤,為病人(尤其是對於不適合接受手術的病人)提供了傳統治療之外的新方案。相對於傳統治療方法,組織碎化治療通常只會引起輕微疼痛,較少副作用和併發症;其無創的特性令住院時間更短、病人康復更快。

作為一所大學教學醫院,港怡期待在將此技術應用至其他不同類型癌症的研究方面作出貢獻,為更多本地和區域內的病人帶來多一個選擇和新希望。


了解更多有關Histotripsy組織碎化技術。
Latest development of treatments for atrial fibrillation 
心房顫動治療最新發展 
Latest development of treatments for atrial fibrillation

Atrial fibrillation is one of the most common types of arrhythmias that can significantly increase stroke risk. To prevent complications associated with stroke and heart failure, some patients are treated with anticoagulants as part of conventional therapy. Minimally invasive ablation has been introduced as an enhanced treatment option, offering a higher success rate compared to the medication treatment and a shorter recovery time. Most patients can be discharged on the next day after the procedure.

In recent years, the emergence of Pulsed Field Ablation (PFA) marks a significant breakthrough in the treatment of atrial fibrillation, offering a promising alternative to existing therapies. Unlike existing non-targeted oriented treatments using heat or cold energy, PFA minimises the chance of damage to surrounding tissues and the occurrence of complications by utilising high-voltage electrical pulses to eliminate cells in atria directly. This approach also shortens the procedure time, providing patients a safer and faster treatment alternative.


Watch the video to learn more about Pulsed Field Ablation.

心房顫動治療最新發展
 
心房顫動屬於常見的心律不正疾病,嚴重可增加中風的風險,傳統治療主要依賴以「薄血丸」等藥物預防中風及心衰竭等併發症。屬微創手術的消融術為心房顫動患者提供更有效的治療方案,其治療成功率較藥物治療高,且術後康復時間短,患者一般可於手術翌日出院。

近年引入的脈衝場消融術為治療心房顫動帶來突破,相比傳統的熱能消融或冷凍消融術,脈衝場消融術以高能量電流更精準地消除心臟異常細胞,可大幅降低對患者其他組織(如食道和橫隔膜神經)的損害風險、減少併發症,並縮短手術時間,為病人提供更安全和快捷的治療選擇。


立即觀看影片了解更多心房顫動治療方案的最新動向,及不同治療方案的詳細資訊。
Gleneagles' column on Sky Post    
 
Gleneagles' Director of Cardiac Catheterization & Intervention Centre and Honorary Consultant in Cardiology Dr Tse Tak-sun shared about the application of non-invasive CT-FFR technology on cardiovascular check-up. Another educational piece on telemedicine and AI was contributed by Gleneagles' Resident Medical Officer Dr Lau Chi-ho Edwin who is responsible for digital health services.

Read on for the full articles (in Chinese only):  
🔎
From conventional cardiovascular imaging to non-invasive CT-FFR technology
🔎Telemedicine and AI: healthcare at your fingertips

晴報專欄「醫語怡情」

港怡醫院心臟導管及介入治療中心總監、心臟科名譽顧問醫生謝德新醫生講解透過無創CT-FFR技術進行心臟血管檢查;港怡醫院現主力負責數碼醫療服務的駐院醫生劉智豪醫生亦透過專欄文章,分享遙距醫療如何結合人工智能提升醫療體驗。

Understanding Frequent Urination and Bladder Health

Frequent urination is a common issue many people may encounter, especially when the need to visit the restroom becomes very frequent that it affects daily life. This could be a warning sign from your bladder about potential health concerns. Dr Lo Ting-kit, Consultant in Urology at Gleneagles Hospital Hong Kong, points out that the causes of frequent urination vary and  include overactive bladder, benign prostatic hyperplasia, excessive intake of diuretic beverages (such as coffee), or even underlying health problems like sleep apnea, heart failure, kidney disorder, prostate or bladder cancer etc.

Definition and Common Causes of Frequent Urination 

Traditionally, urinating more than seven times a day while awake may be considered frequent urination, but this can also be influenced by individual water intake habits, diet, and activity levels. If accompanied by sudden urges to urinate or increased nighttime urination, it could be a sign of overactive bladder. Dr Lo recommends seeking medical advice promptly if frequent urination persists or disrupts daily life to identify the root cause. 


Treatment and Daily Management 

Generally, treatment for overactive bladder can involve medication, lifestyle adjustments, and bladder training. Medications such as anticholinergic agents and Beta-3 agonists can help stabilise bladder muscles in the treatment of overactive bladder. Additionally, reducing the intake of diuretic beverages (like coffee) can also alleviate symptoms. Bladder training can help extend the intervals between urination, gradually improving the issue. If these treatments do not provide satisfactory results, patients may consider percutaneous tibial nerve stimulation (PTNS) to regulate bladder nerves or Botox injections to stabilise the bladder wall. 

🔎 Please click here to watch the interview of Dr Lo Ting-kit on frequent urination related common questions and bladder health (in Cantonese only). 

認識尿頻及膀胱健康

尿頻是許多人可能遇到的問題,在日常生活中頻繁地需要上洗手間,甚至影響到工作或休息,這可能是膀胱發出的健康警號。港怡醫院泌尿外科顧問醫生盧挺傑指出,尿頻的原因多樣,包括膀胱過度活躍症,良性前列腺增生,攝入過多利尿飲品(如咖啡),甚至是潛在的健康問題,如睡眠窒息症,心臟衰竭,腎臟疾病,前列腺或膀胱癌等。

尿頻的定義與常見原因 

傳統上,清醒時每日小便超過七次可能被視為尿頻,但這也受個人喝水習慣、飲食及活動量影響。若伴隨突發性尿急或夜尿增多,則可能是膀胱過度活躍症的表現。盧醫生建議,若尿頻情況持續或影響生活,應及早尋求醫生檢查,找出根本原因。 


治療與日常管理 

一般而言,治療膀胱過度活躍症所引至的尿頻可從藥物、改善生活習慣及訓練膀胱著手。藥物治療如抗膽鹼藥和Beta-3受體促進劑(又稱「 β3-腎上腺素受體激動劑」)可穩定膀胱肌肉。另外,改善生活習慣如減少攝入利尿飲品(如咖啡),也有助改善尿頻情況。訓練膀胱有助延長排尿間隔時間,逐步改善尿頻問題。假如以上治療方案沒有達到理想效果,患者就可以考慮進行脛神經電擊治療以調節膀胱的神經線或肉毒桿菌治療讓膀胱壁穩定。 

🔎 請按此觀看盧挺傑醫生分享有關尿頻常見問題與膀胱健康的訪問。

Gleneagles Hospital Hong Kong
港怡醫院  

Learn about the latest information from Gleneagles Hospital Hong Kong 
了解本院最新資訊 

Website 網站https://gleneagles.hk/

Centre for Health Protection  
衞生防護中心

Provide the latest epidemic information and guidelines in Hong Kong
 提供香港最新的防疫資訊及指引

Website 網站: https://www.chp.gov.hk/tc/index.html

Department of Health 衞生署
Release updated government health policy  
公佈政府衞生政策
 Website 網站:
 https://www.coronavirus.gov.hk/eng/index.html


World Health Organization 世界衛生組織
Provide the latest global epidemic information and guidance  提供全球即時的防疫資訊及指引
Website 網站: http://WHO.int
Social media 社交媒體
Facebook
Email
YouTube
Contact us 聯絡我們
Gleneagles Hospital Hong Kong - 1 Nam Fung Path, Wong Chuk Hang, Hong Kong
港怡醫院香港黃竹坑南風徑 1
Mainline 電話: +852 3153 9000

Website 網站: https://gleneagles.hk/
We are sending this newsletter and other health information to our patients who have shared with us their email contacts. If you do not wish to receive them, please click here to unsubscribe.

我們向已與本院分享電郵地址的病人發放此通訊和其他相關健康資料。
如果您不願意接收相關電郵,請
按此取消訂閱。

Copyright © 2025 Gleneagles Hospital Hong Kong, All rights reserved.

No comments:

Post a Comment